Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ConocoPhillips has added 9% in a week to close at $140.90, and the setup heading into November 5 earnings looks meaningfully different from the one described in last week's note.
The most striking change is the price itself. COP has moved from $129.35 a week ago to $140.90 now, a gain of more than 8.9% that puts it ahead of most of its close peers. OXY gained 5.7% on the week, CVX 4.9%, EOG 6.2%. SM Energy was the closest challenger at 9.8%, and matched COP almost exactly at 8.9%. The sector is broadly bid, but COP is running at or near the top of the group. The prior note put the mean analyst target at $146.88 against a $129.35 price. With COP now at $140.90, that implied upside to the consensus has compressed sharply. The mean target across the coverage universe is $148.04. That leaves a gap of roughly 5%, not 14%.
The positioning picture is not the story here. Short interest remains minimal at 1.2% of free float, up a modest 3.2% on the week and still down slightly on the month. Borrow availability is effectively uncapped, with shares to lend far exceeding what is currently borrowed. Cost to borrow ticked up 22% on the week to 0.42%, but the absolute level remains negligible. The options market is equally calm: the put/call ratio at 0.73 sits fractionally below its 20-day average of 0.74, and the z-score of -0.67 signals nothing out of the ordinary. There is no short pressure, no hedging spike, no squeeze dynamic. The lending market is open and cheap.
The analyst framing set out in last week's note still holds, but the arithmetic has shifted. Jefferies sits at $174 with a Buy. UBS is at $169, also Buy. Morgan Stanley carries Overweight at $151. Barclays holds Overweight at $150, having trimmed slightly in August. Truist Securities is the outlier, raising its target to $136 from $130 but staying at Hold, a target now below the current price. The bull case is concrete: Q4 production modelled at 2,348 Mboe/d, FY26 return of capital modelled at $12.08 billion, or an 8% yield, with record Permian volumes and technology-led productivity gains underpinning the numbers. The bear case centres on commodity price volatility, uncertainty around LNG and power demand, and M&A execution risk. With the stock now trading through several of the more cautious targets, the valuation debate becomes sharper ahead of the November 5 print. The P/E sits at 13.8x and EV/EBITDA at 6.0x, neither extreme for the sector.
The ORTEX short score is running at 29.9, low and stable, consistent with the low-conviction short positioning. The utilization rank of 76 and dividend score of 73 are the factor standouts. The ORTEX stock score note from earlier this week put the overall reading at 82.3, with momentum the key pillar and value the drag: a profile that fits a stock that has run hard and where analysts are debating whether the re-rating has more to go.
The last two earnings prints both produced positive one-day moves, the most recent a gain of 2.2% on the day and 8.2% over the following five sessions. With 22 days to the November 5 release, the question is less about direction of short interest and more about whether the Street's targets, most of which were set before a near-9% weekly gain, can absorb the move or will start catching up again.
See the live data behind this article on ORTEX.
Open COP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
